Multiple Sclerosis Trial, Not Yet Recruiting NCT07257900 Sponsor: Istanbul University - Cerrahpasa Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Not Yet Recruiting

NCT07257900
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People between the ages of 12 and 22 years old.
  • People who have been diagnosed with multiple sclerosis that started in childhood or adolescence, confirmed using a specific set of diagnostic guidelines called the 2017 revised McDonald criteria.
  • People whose level of physical disability, as measured by a standard scale called the EDSS, falls at or below a score of 6 (confirm with trial site for details on what this score means for day-to-day function).
  • People who are able to take part in exercise sessions held online through Zoom.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have bone, joint, or muscle problems that affect their ability to move around.
  • People who experience blurry or disturbed vision that could interfere with exercise or screen-based activity.
  • People who have another medical, neurological, or mental health condition that could affect their physical ability to participate or influence the results of the study.
  • People who have had a flare-up of their condition or received steroid treatment within the past three months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Serhat Güler, Assoc. Prof., Istanbul University-Cerrahpasa Cerrahpasa Faculty of Medicine Department of Pediatric Neurology

Phone: +905326006294

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Istanbul University - Cerrahpasa
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
1 December 2026

Primary endpoints

Timed Up and Go (TUG)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov